Tacrolimus toxicity in rhesus monkey: model for clinical side effects.
Kindt
M V
MV
Department of Safety Assessment, Merck Research Laboratories, West Point, PA 19486, USA.
Kemp
R
R
Allen
H L
HL
Jensen
R D
RD
Patrick
D H
DH
D000818:Animals; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000032:analysis; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D008253:Macaca mulatta; D010179:Pancreas / Q000187:drug effects* / Q000473:pathology; D016559:Tacrolimus / Q000633:toxicity*; D014202:Tremor / Q000139:chemically induced
D007166:Immunosuppressive Agents; D007328:Insulin; D016559:Tacrolimus